Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease
2011

Molecular Subtyping of DCIS: Understanding Breast Cancer Before It Becomes Invasive

Sample size: 188 publication Evidence: moderate

Author Information

Author(s): Clark S E, Warwick J, Carpenter R, Bowen R L, Duffy S W, Jones J L

Primary Institution: Centre for Tumour Biology, Institute of Cancer and CR-UK Clinical Centre, Barts and the London School of Medicine and Dentistry

Hypothesis

Can molecular subtypes of invasive breast cancer be identified in ductal carcinoma in situ (DCIS)?

Conclusion

DCIS can be classified similarly to invasive breast cancer, which may help in understanding disease progression.

Supporting Evidence

  • Each intrinsic molecular subtype of invasive breast cancer can be identified in DCIS.
  • The triple negative and basal-like phenotypes are very uncommon in DCIS.
  • Hierarchical clustering analysis identified three main subtypes of DCIS.

Takeaway

This study looked at breast cancer that hasn't spread yet and found that it can be grouped into types just like more advanced cancers, which helps doctors understand how it might develop.

Methodology

The study used tissue microarrays and immunohistochemistry to analyze 188 cases of DCIS for 16 biomarkers.

Potential Biases

Potential bias due to the retrospective nature of the study and missing data.

Limitations

The study faced challenges with tissue sample loss and the heterogeneity of DCIS.

Participant Demographics

The average age of participants was 56 years, with a range from 25 to 85 years.

Statistical Information

P-Value

0.04

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6606021

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication